期刊文献+

肺癌并肺栓塞17例临床分析 被引量:2

下载PDF
导出
摘要 目的总结肺癌并肺栓塞的临床特征、实验室检查及影像学检查结果,以提高对本病的认识和临床诊治水平。方法肺癌并肺栓塞患者17例,分析其临床表现、实验室检查结果、肺栓塞发生时间、治疗及随访等情况,采用Logistic回归分析方法分析肺癌并发肺栓塞的危险因素。结果 17例患者中不明原因呼吸困难12例,咳嗽11例,发热9例,咯血5例,胸痛4例,心悸5例。血红蛋白(108.7±16.9)g/L,白细胞(8.9±5.3)g/L,D-Dimer(850±536.9)ng/m L,血氧分压(67.3±17.5)mm Hg,血小板(263.6±91.1)g/L。CT检查示肺动脉主干充盈缺损9例,多发肺栓塞5例,胸腔积液3例。彩色多普勒检查示下肢深静脉血栓形成11例,上肢深静脉血栓形成2例,无明显异常4例。病理检查示腺癌13例,鳞癌3例,小细胞癌1例。TNM分期为Ⅰ期+Ⅱ期5例,Ⅲ期+Ⅳ期12例。14例肺栓塞发生于肺癌确诊后前5个月内。17例患者经低分子肝素或华法林抗凝治疗,同时行化疗8例,放疗3例,生物靶向治疗2例。随访至2014年1月31日,17例患者的中位生存时间为5.8个月。Logistic回归分析发现,腺癌、Ⅲ期+Ⅳ期肺癌、血红蛋白<100 g/L、白细胞>11×109/L、D-Dimer>500 ng/m L及血氧分压<80 mm Hg是肺癌并肺栓塞的独立危险因素。结论肺癌并肺栓塞好发于肺腺癌、Ⅲ期+Ⅳ期肺癌、低血红蛋白血症、高白细胞血症患者。不明原因呼吸困难、咳嗽、发热为主要临床表现。实验室检查示血红蛋白降低,白细胞升高。CT肺动脉造影检查示肺动脉主干充盈缺损。四肢血管彩色多普勒检查示深静脉血栓形成。
出处 《山东医药》 CAS 北大核心 2015年第3期31-33,共3页 Shandong Medical Journal
  • 相关文献

参考文献19

  • 1刘丽,贾钰铭,雷开键.肺栓塞与恶性肿瘤[J].四川肿瘤防治,2005,18(1):63-66. 被引量:4
  • 2Lee AY. Epidemiology and management of venous thromboembolism in patients with cancer [J]. Thromb Res, 2003,110(4) :167-172.
  • 3Blom JW, Doggen C J, Osanto S, et al. Malignanicies, protrombot- ic mutiations, and the risk of venous thrombosis ~ J]. JAMA, 2005,293 (6) :715-722.
  • 4肺血栓栓塞症的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2001,24(5):259-264. 被引量:1838
  • 5李娜,王燕.23例肺癌并发肺栓塞的临床分析[J].中国肺癌杂志,2014,17(3):254-259. 被引量:53
  • 6Lee Agnes YY. Epidemiology and management of venous thromboe mbolismin patients with cancer [J]. T hromb Res, 2003, 110 (4) :167-172.
  • 7胡建军.肺癌患者血中D-二聚体和纤维蛋白原水平的变化及临床意义[J].中国现代医生,2011,49(10):51-52. 被引量:18
  • 8Luzzatto G, Schafer AI. The prethrombotic state in cancer[J]. Se- min Oncol, 1990,17(2) :147.
  • 9Blom JW, Doggen C J, Osanto S, et al. Malignanicies, protrombot- ic mutiations, and the risk of venous thrombosis [J]. JAMA, 2005,293 (6) :715-722.
  • 10Mary C, Albert W, Richard H, et al. Deep vein thrombosis and Pulmonary embolismin two cohorts: the longitudinal investigation of thromboembolism etiology [J]. Am J Med, 2004,117 (7) : 19-25.

二级参考文献34

  • 1陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 2Heit JA, Silverstein MD, Mohr DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med, 2000, 160(6): 809-815.
  • 3Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol, 2007, 44(2): 62-69.
  • 4Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 2005, 293(6): 715-722.
  • 5Chuang YM, Yu CJ. Clinical characteristics and outcomes of lung cancer with pulmonary embolism. Oncology, 2009, 77(2): 100-106.
  • 6Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.J Thromb Haemost, 2007, 5(3): 632-634.
  • 7Scarvelis D, Anderson J, Davis L, et al. Hospital mortality due to pulmonary embolism and an evaluation of the usefulness of preventative interventions. Thromb Res, 2010, 125(2): 166-170.
  • 8Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133(6 Suppl): 381S-453S.
  • 9Zangari M, Fink LM, Elice F, et al. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol, 2009, 27(29): 4865 -4873.
  • 10Zhou X, Teegala S, Huen A, et al. Incidence and risk factors of venous thromboembolic events in lymphoma, Am J Med, 2010, 123(10): 935-941.

共引文献1994

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部